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INTRODUCTION
Cervical cancer is the second most common cancer
that affects women in the world.1-4 Apart from that,
it is the most common causes of death among can-
cer, especially for women in developing countries.4
Based on the recent world’s estimation, there are
493,000 new cervical cancer cases occurred each
year, whereas there are 409,400 (83%) cases
happened in women in developing countries and
only 84,400 (17%) cases in developed countries.2
Unfortunately, more than 80% of the cases are
diagnosed at advanced stage when the 5-year
survival rate is less than 40%.2
Abstract
Objective: To know the concealed pre-cancer lesion in women with
invisible squamo-columnar junction (SCJ) by Papsmear examina-
tion.
Method: This study was a descriptive cross-sectional design starting
from August 2014 to March 2015 at several Public Health Cares in
Jakarta. A total of 1,682 subjects were screened by Acetoacetate
Visual Inspection (AVI) examination. After the data was collected,
the process was continued by verification, editing, and coding. The
descriptive analysis showed the percentage of SCJ in age distribu-
tion, the percentage of AVI examination based on SCJ, and the per-
centage of Papsmear examination in invisible SCJ according to nega-
tive AVI result.
Result: There were 1,484 (88.2%) women with the visible SCJ and
198 (11.8%) women with invisible SCJ. The percentage of invisible
SCJ in the menopausal women group was 122 (61,6%); meanwhile,
in the non-menopausal women group, it was 76 (38.4%). Almost
half of the percentage from visible SCJ was found in menopausal
women group 45.8% (103/225 women). The positive AVI result
was 4 (7.1%) in the menopausal women group and 52 (92.9%) in
non-menopausal women group. The result of Papsmear examina-
tion with invisible SCJ were 197 (100%) normal.
Conclusion: Almost half of visible SCJ was found in menopausal
women group. Most of positive AVI result was found in the non-
menopausal women group. All women with the invisible SCJ have a
normal Papsmear result.
[Indones J Obstet Gynecol 2016; 4-3: 158-163]
Keywords: acetoacetate visual inspection, papsmear, pre-cancer le-
sion, squamo-columnar junction
Abstrak
Tujuan: Untuk mengetahui kelainan yang tersembunyi pada keadaan
sambungan skuamo-kolumnar (SSK) tidak tampak melalui pemerik-saan Papsmear.
Metode: Penelitian ini merupakan deskriptif potong lintang. Peneli-tian dilakukan pada periode Agustus 2014 sampai Maret 2015 di be-
berapa puskesmas di Jakarta. Sebanyak 1.682 subjek yang dilakukan
pemeriksaan IVA (Inspeksi Visual dengan Asam asetat). Setelah datadikumpulkan, akan dilakukan verifikasi data, editing, dan proses
pengkodean. Analisis data deskriptif berupa variabel kategori yaitupersentase letak SSK berdasarkan distribusi usia, persentase hasil pe-
meriksaan IVA berdasarkan SSK, dan persentase hasil pemeriksaan
Papsmear pada SSK yang tidak tampak dari hasil pemeriksaan IVAnegatif.
Hasil: Perempuan dengan SSK yang tampak 1.484 (88,2%), yang ti-dak tampak 198 (11,8%). Sambungan Skuamo-Kolumnar (SSK) yang
tidak tampak pada perempuan yang sudah menopause sebanyak 122(61,6%), sedangkan pada perempuan yang belum menopause se-
banyak 76 (38,4%). Hampir setengahnya proporsi SSK yang tampak
didapatkan pada kelompok perempuan yang sudah menopause45,78% (103/225 perempuan). Hasil pemeriksaan IVA positif dida-
patkan 4 (7,1%) pada kelompok perempuan menopause dan 52
(92,9%) pada kelompok perempuan yang belum menopause. Padapemeriksaan Papsmear dengan SSK yang tidak tampak, persentase
kelainan lesi prakanker yaitu sebesar 197 (100%) normal.
Kesimpulan: Hampir setengahnya SSK yang tampak ditemukan pada
kelompok perempuan menopause. Sebagian besar IVA positif dite-mukan pada kelompok perempuan yang belum menopause. Seluruh
perempuan dengan SSK yang tidak tampak memiliki hasil pemerik-
saan Papsmear normal.
[Maj Obstet Ginekol Indones 2016; 4-3: 158-163]
Kata  kunci: IVA, lesi prakanker, papsmear, sambungan skuamo-
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The main cause of high incidence of cervical can-
cer in developing countries is due to the lack of
effective screening programs to detect and manage
the early stage of cervical cancer or pre-cancer le-
sions of the stage.4 Of the various modality screen-
ing which have been studied, Papsmear has ability
to decrease 70% of cervical cancer cases; however,
this examination is difficult to implement in deve-
loping countries like Indonesia. It seems that visual
inspection of the cervix is the best techniques to
apply, especially in areas with limitation of health
facilities resources.2,4-7 This technique is known as
the VIA test (Visual Inspection with Acetic acid ap-
plication). It is defined as a technique of cervical
direct observation after being applied with acetic
acid without the use of any magnifying tools.
Visual Inspection of Acetic acid examination de-
pends on the Squamo-Columnar Junction (SCJ)
condition in the cervical region. In childbearing age
women and pregnant women, SCJ is located in the
ecto-cervical that it can be seen on direct examina-
tion. Whereas in postmenopausal women, SCJ is
often located in the endo-cervical canal so it cannot
be seen on direct observation. However, the per-
centage of visible SCJ in menopausal women is
64.28% and invisible SCJ is 11.66%.8 This rate is
high for the menopausal women. Another study
conducted by Dhaubhadel, et al. prospectively and
descriptively in women aged 20-50 years, the re-
sult showed negative VIA Papsmear test from all
46-50 year of group women.2 The study did not
describe the visibility of SCJ in the investigation.
Therefore, it could make the false negative results.
If the SCJ is not visible, it suggests doing the Pap
smear test. Unfortunately, the problem is in the
first-line health care facility, such as primary health
centers with limited facilities, the invisible SCJ (in
the second examination), particularly in meno-
pausal women is justified without doing the VIA
examination. Therefore, this study aims to deter-
mine the percentage of hidden invisible SCJ in ab-
normal cervical pre-cancer lesions through the Pap
smear examination.
THEORITICAL OVERVIEW
Invasive cervical cancer is usually preceded by a
long phase of pre-invasive lesions, which are mi-
croscopically seen as precursor lesions developing
from atypical cells to the various level of cervical
intraepithelial neoplasia (CIN) before progression
to invasive carcinoma. The epidemiological studies
have identified several risk factors that contribute
to the development of the CIN and cervical cancer.
The risk factors are Human Papilloma Viral (HPV)
infection, sexual contact in early age, changing sex-
ual partners, multi-parity, long-term of oral contra-
ceptive use, smoking, low socioeconomic status, in-
fection with Chlamydia trachomatis, micronutrient
deficiency described by less intake of vegetables
and fruits. The types of HPV 16, 18, 31, 33, 35, 39,
45, 51, 52, 56, 58, 59 and 68 are closely related to
CIN and invasive cancer. Infection of one or more
HPV types is suspected as the cause of cervical neo-
plasia. Infection of one or more of the oncogenic
HPV types will contribute to the entrance of com-
bined viral genome into the host cell genome; this
formation will lead to cell neoplasia and turn into
various level of CIN and finally, it will further de-
velop into cervical cancer.9-13
Application of 5% acetic acid is believed to cause
a reversible coagulation or precipitation of the cell
protein. This application also causes swelling of the
epithelial tissue and cell dehydration. The color of
normal squamous epithelium is pink; while, the co-
lumnar epithelium will be in red color due to the
reflection of light from the stroma in which its bot-
tom is rich for blood vessels. If the epithelium con-
tains a lot of protein cells, the acetic acid will coa-
gulate this protein which will eliminate the color
of the stroma. The result from this coagulation pro-
duction is called as aceto-white area that can be
seen with the naked eye and distinguished from
the normal area which should be pink around it.
Therefore, the effect of acetic acid depends on the
amount of protein found in epithelial cells. Areas
where the increased activity of the nucleus and
DNA will change very clearly.9,13
When acetic acid is applied to normal squamous
epithelium, the coagulation will occur in the super-
ficial cell layer. Although the deeper part of the cell
has more protein core, acetic acid cannot pene-
trate; thus, the result of precipitation is not suffi-
cient enough to remove the color in the stroma.
The CIN region and invasive cancer are an area
where the protein coagulation will occur maxi-
mally because they contain of higher core protein
and prevent light passing through the epithelium.
As a result, the arrangement of blood vessels in the
sub-epithelial disappears that the thick epithelium
appears white. In the CIN, aceto-white area is limi-
ted to the transformation zone close to the SCJ;
while, in cervical cancer, aceto-white area is seen
around the cervix. Aceto-white area is not typical
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for the CIN and early stage of cancer. This area can
also be seen in other conditions due to the increase
of core proteins, such as immature squamous me-
taplasia, healing or regenerating epithelium (asso-
ciated with inflammation), leucoplakia (hyperkera-
tosis), and condyloma.9,12,13 The symptoms of cer-
vical cancer are vaginal bleeding, post-coital
bleeding, vaginal discharge, lower abdominal pain,
edema of lower extremity, obstructive uropathy,
bowel obstruction, and also anemia.12,14
Aceto-white area in CIN and early stage of can-
cer are more whitish, thicker, and opaque as well
as clear boundary; while, the aceto-white area in
immature squamous metaplasia, the inflammation
and regenerating epithelium will make less pale,
thin, translucent, and ill defined. Aceto-white area
caused by inflammation and epithelial healing
process is usually spread to the cervix, not only in
the transformation zone. Besides, this color will be
disappeared within a minute. Leucoplakia and con-
dyloma turn the color into grayish white after the
application of acetic acid. The effect of acetic acid
(aceto-white area) is slower in CIN lesions and
early invasive cancer than immature squamous
metaplasia and inflammation. This effect occurs af-
ter 3-5 minutes at CIN 2-3 and invasive cancer.9,13
METHODS
This cross-sectional design study is conducted in
several primary health centers in Jakarta on the pe-
riod of August 2014 to March 2015. The target
population is all women who are married or have
ever had sexual intercourse for VIA examination.
We included women who did the VIA screening
examination in primary health centers Jakarta in
the period of August 2014 to March 2015. We ex-
cluded pregnant women and women with history
of total hysterectomy. From the calculation for-
mula, the total number of subjects needed in this
study is 1,658 subjects. In this study, we performed
VIA examination on 1,682 women.
All women that met the criteria of the study
were labeled and subsequently did the Papsmear
examination and the results were interpreted by
expert pathologist. The result of Papsmear exami-
nation would be described with Bethesda system
criteria in 2001. The data was analyzed where we
conducted the descriptive statistics for categorical
variables, namely the proportion of SCJ layout
based on the age distribution, the proportion of the
VIA examination results based on the location of
the SCJ of the age distribution, and the percentage
of the Papsmear examination results of the SCJ
which was not visible from the IVA. All data were
shown in frequency and percentage.
RESULTS
Of 1,682 subjects, only 9 (0.5%), 311 (18.5%), 638
(37.9), 492 (29.3), 232 (13.8%) women were less
than 20, 20-29, 30-39, 40-49, and more than 50
years old; respectively.
Table 1. The Characteristics of the Subjects
Characteristics n %
Age
< 20 yo 9 .5
20-29 yo 311 18.5
30-39 yo 638 37.9
40-49 yo 492 29.3
 50 yo 232 13.8
Menopause state
Not yet 1457 86.6
Menopause 225 13.4
Contraception state
Not using contraception 354 21.0
Pill 127 7.6
Implant 43 2.6
Injection 603 35.9
IUD 470 27.9
MOW 27 1.6
Condom 58 3.4
SCJ
Invisible SCJ 198 11.8
Visible SCJ 1484 88.2
Total 1682 100.0
In this study, according to the age group, we di-
vided into group who were still menstruation (pre-
menopausal state) and had stopped menstruation
(menopausal state). There were 1,457 (86.6%) wo-
men who were still menstruation (premenopausal)
and the others had stopped menstruation.
Table 1 showed that the majority of women
(603 women (35.9%)) had ever used the injectable
contraception. Meanwhile, the rate of permanent
contraceptive acceptor (MOW) was only 27 (1.6%)
women. There were 354 (21.0%) women had not
ever used contraception. There were 1,484
(88.2%) women with visible SCJ and 198 (11.8%)
women with invisible SCJ. The proportion of invi-
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sible SCJ based on age group for more than 50, 40-
49, 30-39, 20-29, less than 20 years old was 127
(64.1%), 35 (17.7%), 30 (15.2%), 6 (3.0%), and 0
(0.0%); consecutively.
Invisible SCJ proportion in women who had ex-
perienced menopause was 122 (61.6%) and 76
(38.4%) for premenopausal women. Almost half of
visible SCJ obtained in the group of women who
were menopausal (45.78% (103 women)).
Table 2 depicted the proportion of visible SCJ.
For age group of 30-39, 40-49, 20-29, and less than
20 years old, there were 608 (41.0%), 457 (30.8%),
305 (20.6%), and 9 (0.6%); consecutively. The pro-
portion of visible SCJ in menopausal women was
103 (6.9%) and 1,381 (93.1%) women in preme-
nopausal state. However, in the premenopausal
group, nearly half of 103 (45.77%) women had
visible SCJ.
Table 2. The Proportion of Squamo-Columnar Junction 
     (SCJ)
Characteristic SCJ
Invisible SCJ % Visible SCJ %
Age
< 20 yo 0 0.0 9 0.6
20-29 yo 6 3.0 305 20.6
30-39 yo 30 15.2 608 41.0
40-49 yo 35 17.7 457 30.8
 50 yo 127 64.1 105 7.1
Menopause State
Not Yet 76 38.4 1381 93.1
Menopause 122 61.6 103 6.9
Table 3. Proportion of VIA Examination with Visible SCJ
Characteristic VIA
Negative % Positive %
Age
< 20 yo 8 0.6 1 1.8
20-29 yo 291 20.4 14 25.0
30-39 yo 589 41.2 19 33.9
40-49 yo 439 30.7 18 32.1
 50 yo 101 7.1 4 7.1
Menopause State
Not Yet 1329 93.1 52 92.9
Menopause 99 6.9 4 7.1
In this study, the overall positive VIA test result
was in 56 (3.98%) women. The proportion of posi-
tive VIA test result according to the age group were
19 (33.9%) for 30-39 years old, 18 (32.1%) for 40-
49 years old, 14 (25.0%) for 20- 29 years old, 4
(7.1%) for more than 50 years old, and 1 (1.8%)
for less than 20 years old. While, the proportion of
positive VIA test result was obtained for 4 (7.1%)
in menopausal women and 52 (92.9%) in menstru-
ating women (Table 3).
In the Pap test with SCJ which was not visible,
every test presented the normal result (100%) (Ta-
ble 4). In this study, invisible SCJ was obtained in
198 subjects, but there was one subject that was
not checked due to loss of data. However, this num-
ber still met the minimum of required sample (196
subjects).
DISCUSSION
This study is based on the data from the examina-
tion in several health centers in Jakarta. In this
study, the total of 1,682 women were analyzed
Table 4. Proportion of Papsmear Test Result in Invisible SCJ
ASCUS % LSIL % HSIL % Normal %
Age
20-29 yo 0 0.0 0 0.0 0 0.0 6 3.0
30-39 yo 0 0.0 0 0.0 0 0.0 27 13.7
40-49 yo 0 0.0 0 0.0 0 0.0 36 18.3
 50 yo 0 0.0 0 0.0 0 0.0 128 65.0
Menopause stase
Not Yet 0 0.0 0 0.0 0 0.0 74 37.6
Menopause 0 0.0 0 0.0 0 0.0 123 62.4
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based on their characteristics of age, history of con-
traception, menopausal status, state of the SCJ, the
results of the VIA examination and Papsmear. This
study began between August 2014 and March
2015. Women with positive VIA test result were
evaluated on subsequent visits. While the women
had cervical abnormalities, such as cervicitis, it
would be treated with topical antiseptics. If the
doctor found other abnormalities, such as cervical
polyps and suspicious cancer, the women would be
sent to higher level of health care facility.
This study has strengths and limitations. The
strengths of this study were the sample was taken
by doctors and health workers who have had the
training and experience from the Female Cancer
Program (FCP) in identifying the SCJ, the abnor-
malities in the cervical region, the procedures for
VIA and conventional smear of Pap-smear exami-
nation sampling. Additionally, in this study, one pa-
thologist performed Papsmear examination. There
were some flaws in this study among others,
namely in the Pap-smear examination, sampling
errors might occur that could affect the results.
In this study, there were 225 (13.37%) meno-
pausal women. The proportion of invisible SCJ was
among 198 (11.7%) women, whereas almost half
of postmenopausal women had visible SCJ. In the
study conducted by Nuranna, et al. in October 2007
until December 2010, it showed that of 3,791 post-
menopausal women (16.49%), the proportion of
invisible SCJ was on 2,680 (70.69%) women. More
than half of the menopausal women had visible SCJ
(2,437 (64.28%) women).8
In this study, in Pap-smear with invisible SCJ, all
results showed normal (100%). Shwe, et al. con-
ducted a study of cervical cytology in Myanmar
from 2010 to 2011. Of 1,771 women screened, 762
women (43.0%) resulted in abnormal smear, 866
(48.9%) and 87 (4.9%) were diagnosed as inflam-
mation and Atypical Squamous Cells of Undeter-
mined Significance (ASCUS). There were 42 (2.3%)
and 11 (0.6%) cases of Low Grade Squamous In-
traepithelial Lesion (LSIL) and High Grade Squa-
mous Intraepithelial Lesion (HSIL). The cases of
squamous cell carcinoma (SCC) occurred on 3
(0.2%) women.15 While the study conducted by
Sengul, et al., there were 32,578 cases of Pap-smear
examination performed and analyzed between Ja-
nuary 2001 and April 2010. From the investigation
which had carried out, the results showed that
1.18% of ASCUS; 0.39% of LSIL; 0.16% of HSIL;
0.07% of Atypical Glandular Cells of Undetermined
Significance (AGUS); 0.02% of squamous cell carci-
noma, and 0.006% of adenocarcinoma 0.006%.16
Abnormal cytology is more common in cases with
older age, low parity, and period of perimeno-
pause.16 However, this study did not have data on
SCJ picture.
In this study, all results were 100% normal cer-
vical cytology at the invisible SCJ. However, this did
not completely rule out pre-cancer lesions abnor-
malities. Study by Pan, et al. explained that overall,
the level of sensitivity, specificity, positive predic-
tive value, negative predictive value, and accuracy
of cervical cytology for detecting cervical intraepi-
thelial neoplasia (NIS 2+) were respectively 81.0
%, 95.4%, 38.3%, 99.3% and 94.9%.17 A study held
by Pak, et al. which aimed to compare the history
of previous Papsmear test result in patients with
cervical adenocarcinoma and squamous cell carci-
noma of the cervix. In patients with cervical ade-
nocarcinoma, the false negative results of Pap-
smear were very significant in the latest investiga-
tion. As already mentioned above, the normal
Papsmear results did not guarantee not to develop
the cervical cancer. In general, 157 patients
(41.8%) carried out repeated screening within 2
years. Fifty-five (14.6%) carried out repeated
screening within 2-5 years and 80 (22.3%) over 5
years. A total of 16.8% did not have documentation
for Pap-smear examination results. The false nega-
tive results of Pap-smear for patients with cervical
adenocarcinoma and squamous cell carcinoma
were 9 (5.6%) and 2 (1.3%) patients.18 Kirschner,
et al. stated that the false negative of Pap-smear
result was on 11 (9.8%) women.19
CONCLUSION
Almost half of invisible SCJ is found in the group of
menopausal women and most visible SCJ is found
in the group of women who have not menopausal
yet. Positive VIA results are largely found in the
group of women who have not menopausal yet. All
the women with invisible SCJ have normal
Papsmear examination results.
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